|Articles|November 6, 2013

ACT 2014 e-media kit

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content

Proactive Planning is Key to Mitigating Study Rescue

ByAshley Daigneau

November 14th 2025

ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results

ByAndy Studna, Senior Editor

November 14th 2025

© Ezume Images - © Ezume Images - stock.adobe.com

Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV

ByAndy Studna, Senior Editor

November 13th 2025

© tippapatt - © tippapatt - stock.adobe.com

Advarra and IgniteData Partner to Streamline eSource-to-EDC Data Transfer

ByAndy Studna, Senior Editor

November 13th 2025

Improving Site Satisfaction Through Better Technology and Collaboration

ByAndy Studna, Senior Editor

November 13th 2025

ACT 2014 e-media kit

Newsletter

Related Content

Proactive Planning is Key to Mitigating Study Rescue

ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results

Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV

Advarra and IgniteData Partner to Streamline eSource-to-EDC Data Transfer

Improving Site Satisfaction Through Better Technology and Collaboration

Trending on Applied Clinical Trials Online

Gilead’s Single-Tablet Bictegravi/Lenacapavir Regimen Shows Positive Phase III ARTISTRY-1 Results in Virologically Suppressed Adults with HIV

Advarra and IgniteData Partner to Streamline eSource-to-EDC Data Transfer

ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results

Improving Site Satisfaction Through Better Technology and Collaboration

Proactive Planning is Key to Mitigating Study Rescue